Evidence map›Paper›PMID 25479749›Full record

ArticleCell stem cell2014

SET7/9 methylation of the pluripotency factor LIN28A is a nucleolar localization mechanism that blocks let-7 biogenesis in human ESCs.

Seung-Kyoon Kim, Hosuk Lee, Kyumin Han, Sang Cheol Kim, Yoonjung Choi, Sang-Wook Park, Geunu Bak, Younghoon Lee, Jung Kyoon Choi, Tae-Kyung Kim and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell stem cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Modification of the Transcription Factor FOXL2 at Serines 101 and 107 Disables DNA Binding, Leads to Nucleolar Relocalization, and Rewires Granulosa-Cell Programs.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Lin28/let-7 axis in breast cancer.Molecular biology reports · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Seung-Kyoon KimDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea.
Hosuk LeeDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea.
Kyumin HanDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea.
Sang Cheol KimSamsung Genome Institute, Samsung Medical Center, Seoul 135-710, Republic of Korea.
Yoonjung ChoiDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea.
Sang-Wook ParkDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea.
Geunu BakDepartment of Chemistry, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea.
Younghoon LeeDepartment of Chemistry, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea.
Jung Kyoon ChoiDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea.
Tae-Kyung KimDepartment of Neuroscience, The University of Texas Southwestern Medical Center, Dallas, TX 75390-9111, USA.
Yong-Mahn HanDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea. Electronic address: ymhan@kaist.ac.kr.
Daeyoup LeeDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea. Electronic address: daeyoup@kaist.ac.kr.
Korea Advanced Institute of Science and Technology · KRThe University of Texas Southwestern Medical Center · US

Funding

The epigenetic mechanism of enhancer RNA in behavioral plasticityR01NS085418 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI KIM, TAE-KYUNG · 2013 to 2017
$1.7M
NINDS NIH HHS R01 NS085418
6 · The paper itself

Abstract

LIN28-mediated processing of the microRNA (miRNA) let-7 has emerged as a multilevel program that controls self-renewal in embryonic stem cells. LIN28A is believed to act primarily in the cytoplasm together with TUT4/7 to prevent final maturation of let-7 by Dicer, whereas LIN28B has been suggested to preferentially act on nuclear processing of let-7. Here, we find that SET7/9 monomethylation in a putative nucleolar localization region of LIN28A increases its nuclear retention and protein stability. In the nucleoli of human embryonic stem cells, methylated LIN28A sequesters pri-let-7 and blocks its processing independently of TUT4/7. The nuclear form of LIN28A regulates transcriptional changes in MYC-pathway targets, thereby maintaining stemness programs and inhibiting expression of early lineage-specific markers. These findings provide insight into the molecular mechanism underlying the posttranslational methylation of nuclear LIN28A and its ability to modulate pluripotency by repressing let-7 miRNA expression in human embryonic stem cells.

Indexed as

Cell DifferentiationCell LineCell LineageCell NucleolusDNA-Binding ProteinsEmbryonic Stem CellsGenes, mycHistone-Lysine N-MethyltransferaseHumansMethylationMicroRNAsPluripotent Stem CellsProtein MultimerizationProtein TransportRNA-Binding ProteinsDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseKMT5A protein, humanLIN28B protein, humanMicroRNAsmirnlet7 microRNA, humanRNA-Binding ProteinsTUT4 protein, human

Identifiers

PMID25479749
PMCPMC4258232
OpenAlexW2028898542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.